Why swollen legs after Fem-Pop bypass deserve more attention – and what could change the game

02 Sep Why swollen legs after Fem-Pop bypass deserve more attention – and what could change the game

At Firstkind, we speak to vascular teams every day who tell us the same thing: post-operative swelling is most often expected, but frustrating. It delays healing, causes discomfort, and slows patient rehabilitation — yet, surprisingly, it’s often accepted as routine.

We believe it’s time to challenge that.

In this latest blog, we discuss, “Tackling the Swollen Leg After Fem-Pop Bypass: What We Know — and What Could Change the Game,”. We take a closer look at what’s really driving this complication, and explore how the geko® device, used in other clinical settings, is offering a new solution to an old problem.

Click here to read the blog: Tackling the Swollen Leg After Femoropopliteal Bypass: What We Know – and What Could Change the Game – Firstkind

Post-op edema: More than a minor setback

Swelling post-surgery isn’t just a cosmetic or comfort issue. It’s a barrier to wound healing, mobility, and overall recovery. While conventional strategies like compression and elevation help, they rely heavily on patient compliance and mobility — which can be limited in the immediate post-op period.

Our article breaks down the multifactorial causes of edema, including:

• • Lymphatic disruption
  • Reperfusion injury
  • Capillary leak and inflammation

And importantly, it asks: What if we could intervene earlier, more effectively — and without relying on patient effort?

Where the geko device fits in

The geko device is a small, wearable neuromuscular stimulator worn just below the knee. It gently stimulates the common peroneal nerve, activating the the calf and foot muscle pumps, and significantly increasing venous, arterial, and microcirculatory blood flow — all without requiring the patient to move.

In the article, we highlight how this mechanism:

• • Supports edema reduction
  • Offers additional protection against Venous Thromboembolism (VTE – blood clots)
  • Provides a passive, continuous therapy — ideal for early post-op care

It’s already NICE-endorsed (MTG19), and FDA cleared for patients at high risk of VTE who can’t tolerate pharmacologic prophylaxis, and we’re seeing encouraging clinical results across multiple therapy areas (for which the geko device is indicated), including the reduction of orthopaedic related pre- and post-operative oedema, the acceleration of chronic wound healing (leg ulcers), and the prevention of blood clots, in particular immediately post-Stroke.

A call to action

We are always actively looking to partner with vascular clinicians who want to explore how the geko device could benefit their patients — and to help close the evidence gap in application areas, such as Fem Pop by-pass.

If you’re interested in bringing the geko device into your clinical setting, or in running a service evaluation, we’d love to hear from you.

Contact: Mark.Sacaris@firstkindmedical.com